• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-CCP; ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-CCP; ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP) Back to Search Results
Catalog Number 07251670190
Device Problems Low Test Results (2458); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/25/2023
Event Type  malfunction  
Manufacturer Narrative
The e801 analyzer serial number is (b)(6).Qc was acceptable.The customer repeated 5 other patient samples for troubleshooting purposes and the results were reproducible.The investigation is ongoing.H3 other text : na.
 
Event Description
The initial reporter complained of a discrepant low result for 1 patient sample tested for elecsys anti-ccp (anti-ccp) on a cobas e 801 analytical unit.The initial result was 14.4 u/ml.This result was reported outside of the laboratory where it was questioned by the patient.On (b)(6) 2023 the sample was repeated with results of 23.6 u/ml, 21 u/ml, and 20.8 u/ml.On (b)(6) 2023 the sample was repeated in the morning with a result of 30.2 u/ml.The sample was repeated later that afternoon with a result of 23.7 u/ml.All of the repeat results were more consistent with the patient¿s clinical condition.
 
Manufacturer Narrative
Calibration and qc were acceptable.Data from calibration and qc do not point to a general reagent or instrument issue.Sample quality issues were not identified from the camera images provided.Based on the information provided, the cause of the event could not be determined.The investigation did not identify a product problem.
 
Manufacturer Narrative
Additional anti-ccp repeat results were provided from the sample obtained on (b)(6) 2023: 18 u/ml, 17.2 u/ml and 17.1 u/ml.On (b)(6) 2023 the patient had an anti-ccp result of 30.54 u/ml.The sample from (b)(6) 2023 was repeated with a result of 0.8 u/ml.The low results are in question.The investigation is ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-CCP
Type of Device
ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP)
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key17145818
MDR Text Key317918308
Report Number1823260-2023-02013
Device Sequence Number1
Product Code NHX
UDI-Device Identifier04015630940370
UDI-Public04015630940370
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K081338
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 09/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Catalogue Number07251670190
Device Lot Number660228
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
LEFLUNOMIDE.
Patient Age24 YR
Patient SexFemale
-
-